astrazeneca glp-1 AstraZeneca, Eccogene Enter Exclusive License Agreement for Drug AstraZeneca's Elecoglipron Advances in Oral
Description
A new weight loss center has opened in Baton Rouge, offering patients access to GLP-1 medications and personalized lifestyle guidance.
Our model brings together access to providers, technology infrastructure, and a modern consumer experience across verticals like medical weight loss, hormone therapy, wellness, and medspa services.
Learn about expected results, dosage impact, and expert tips to maximize your weight loss journey.
A bipartisan bill soon to be introduced in the state Legislature seeks to decrease the cost of GLP-1 drugs in Pennsylvania
Personalized plans, expert guidance, and FDA-approved injections like Wegovy, Mounjaro, Contrave, Ozempic, and Qsymia.
Evidence-based guidance you need.
